Abstract
Data on the safety of antipsychotic use during pregnancy remain inconclusive. Here, we report the history of a woman with schizophrenia who had two pregnancies while receiving prolactin-sparing antipyschotic drugs. The case supports existing data showing that the use of olanzapine and clozapine (on separate occasions) during pregnancy results in uncomplicated deliveries of healthy infants.
References
Laursen TM, Munk-Olsen T. Reproductive patterns in psychotic patients. Schizophr Res. 2010;121(1–3):234–40.
Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry. 2005;50(14):892–900.
Jones I, Chandra PS, Dazzan P, et al. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet. 2014;384(9956):1789–99.
Miller LJ, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv. 1996;47(5):502–6.
Gentile S. Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull. 2010;36(3):518–44.
Raha S, Taylor VH, Holloway AC. Effect of atypical antipsychotics on fetal growth: is the placenta involved? J Pregnancy. 2012;2012:315203.
McCauley-Elsom K, Gurvich C, Elsom SJ, et al. Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs. 2010;17(2):97–104.
Lin HC, Chen IJ, Chen YH, et al. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res. 2010;116(1):55–60.
Brunner E, Falk DM, Jones M, et al. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol. 2013;14:38.
Arora M, Praharaj SK. Meningocele and ankyloblepharon following in utero exposure to olanzapine. Eur Psychiatry. 2006;21(5):345–6.
McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):444–9.
Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20(4):399–403.
Spyropoulou AC, Zervas IM, Soldatos CR. Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association. Arch Womens Ment Health. 2006;9(4):219–22.
Yeshayahu Y. The use of olanzapine in pregnancy and congenital cardiac and musculoskeletal abnormalities. Am J Psychiatry. 2007;164(11):1759–60.
McMahon DM, Liu J, Zhang H, et al. Maternal obesity, folate intake, and neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol. 2013;97(2):115–22.
Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164(8):1214–20.
Vavrusova L, Konikova M. Clozapine administration during pregnancy [in Czechoslovakian]. Ceska Slov Psychiatr. 1998;94:282–5.
Karakula H, Szajer K, Rpila B, et al. Clozapine and pregnancy: a case history. Pharmacopsychiatry. 2004;37(6):303–4.
Gentile S. Pregnancy exposure to second-generation antipsychotics and the risk of gestational diabetes. Expert Opin Drug Saf. 2014;13(12):1583–90.
Acknowledgments
Informed consent was obtained from the patient’s legal guardian.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Rugül Köse Çinar declares no conflicts of interest.
Funding
No sources of funding were used in the preparation of the manuscript.
Rights and permissions
About this article
Cite this article
Köse Çınar, R. Olanzapine and clozapine use in a woman with schizophrenia during consecutive pregnancies: a case report. Drugs Ther Perspect 32, 403–405 (2016). https://doi.org/10.1007/s40267-016-0328-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-016-0328-z